loading...| Preferred Name |
Tumor Lysis Syndrome [Disease/Finding] |
|
| Synonyms |
Tumor Lysis Syndrome |
|
| ID |
http://purl.bioontology.org/ontology/NDFRT/N0000003216 |
|
| altLabel |
Tumor Lysis Syndrome Tumour Lysis Syndrome |
|
| cui |
C0041364 |
|
| May be prevented by |
http://purl.bioontology.org/ontology/NDFRT/N0000150847 http://purl.bioontology.org/ontology/NDFRT/N0000150845 http://purl.bioontology.org/ontology/NDFRT/N0000150848 http://purl.bioontology.org/ontology/NDFRT/N0000150846 |
|
| May be treated by |
http://purl.bioontology.org/ontology/NDFRT/N0000148794 |
|
| MESH DEFINITION |
A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia. |
|
| MESH DUI |
D015275 |
|
| MeSH name |
Tumor Lysis Syndrome |
|
| MESH UI |
M0023515 |
|
| NDFRT kind |
DISEASE_KIND |
|
| notation |
N0000003216 |
|
| NUI |
N0000003216 |
|
| prefLabel |
Tumor Lysis Syndrome [Disease/Finding] |
|
| SNOMED CID |
277605001 |
|
| tui |
T047 |
|
| subClassOf |